Here are five other recent ratings for Smith & Nephew:
• JPMorgan & Chase Co.: Neutral rating
• BNP Paribas: Outperform rating
• AlphaValue: Buy rating
• Sanford C. Bernstein: Outperform rating
• Consensus rating is “Hold”
The average price target of GBX 1,135.63 is $16.99.
More articles on orthopedic devices:
Spine device stock report: 5 key companies—April 23
Medacta makes huge donation to OREF
8 huge trends in venture capital money for healthcare start-ups
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
